-transparent.png){kind=logo}
Expression of insulin-like growth factor binding protein-1 (IGFBP-1) messenger RNA (mRNA) was studied in tissues of human fetuses from 15 to 23 weeks of gestation. Northern blot analysis revealed IGFBP-1 mRNA in the fetal liver and kidney but not in other fetal tissues, including the brain, heart, lung, skeletal muscle and spleen. Studies by in situ hybridization histochemistry showed that, in all fetal kidneys tested, the IGFBP-1 mRNA was localized preferentially to the epithelial cells of the collecting ducts, as well as to the cells of developing glomeruli and in the subcapsular nephrogenic mesenchyme. Less intense labeling for IGFBP-1 mRNA was seen in the connective tissue stroma of the medullary pyramids. A weak signal was detected in the mature glomeruli, and in the cells of the medullary mesenchyme and capsular connective tissue. IGFBP-1 protein was detected by immunoperoxidase staining mostly around small blood vessels but not in the respective endothelium. The protein was also present in many epithelial cells of the collecting ducts and in stromal connective tissue. These results show that the predominant sites of IGFBP-1 transcription in the developing kidney are those with most active differentiation.
A M Suikkari, and
I Leivo, and
M Kämäräinen, and
H Holthöfer, and
M Seppälä, and
M Julkunen, and
R Koistinen
January 2000,
Biochemical and biophysical research communications,
A M Suikkari, and
I Leivo, and
M Kämäräinen, and
H Holthöfer, and
M Seppälä, and
M Julkunen, and
R Koistinen
February 1993,
The Journal of endocrinology,
A M Suikkari, and
I Leivo, and
M Kämäräinen, and
H Holthöfer, and
M Seppälä, and
M Julkunen, and
R Koistinen
February 1992,
Early human development,
A M Suikkari, and
I Leivo, and
M Kämäräinen, and
H Holthöfer, and
M Seppälä, and
M Julkunen, and
R Koistinen
January 1992,
The Journal of endocrinology,
A M Suikkari, and
I Leivo, and
M Kämäräinen, and
H Holthöfer, and
M Seppälä, and
M Julkunen, and
R Koistinen
May 1990,
Clinical endocrinology,
A M Suikkari, and
I Leivo, and
M Kämäräinen, and
H Holthöfer, and
M Seppälä, and
M Julkunen, and
R Koistinen
June 2018,
Journal of hematology & oncology,
A M Suikkari, and
I Leivo, and
M Kämäräinen, and
H Holthöfer, and
M Seppälä, and
M Julkunen, and
R Koistinen
January 2000,
Human reproduction (Oxford, England),
A M Suikkari, and
I Leivo, and
M Kämäräinen, and
H Holthöfer, and
M Seppälä, and
M Julkunen, and
R Koistinen
January 2003,
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy,
A M Suikkari, and
I Leivo, and
M Kämäräinen, and
H Holthöfer, and
M Seppälä, and
M Julkunen, and
R Koistinen
October 2009,
Virology,
A M Suikkari, and
I Leivo, and
M Kämäräinen, and
H Holthöfer, and
M Seppälä, and
M Julkunen, and
R Koistinen
April 1997,
American journal of obstetrics and gynecology,
